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with normal serum T, and low TSH, 10 of 11 with high uptake were clinically hyperthyroid whereas only two of 18 with normal uptake were. The sensitivity, specificity and positive predictive value of pertechnetate uptake measurements were 83%, 94% and 91 %, respectively. The measurement of pertechnetate uptake is a rapid investigation and may help in the interpretation of patients with undetectable serum TSH found in the presence of normal serum T,.
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With the advent of immunometric sensitive thyroid stimulating hormone (TSH) assays, the biochemical diagnosis of hyperthyroidism has improved.' However, the diagnosis may remain unclear in patients who are found to have normal circulating levels of thyroid hormones with subnormal basal TSH levels and diminished response to thyrotrophin releasing hormone (TRH) . l4 This hormone profile has been found with multinodular goitres, diffuse goitres, solitary nodules and ophthalmic Graves d i s e a~e l -~~~ and may indicate preclinical hyperthyroidi~m.~
The investigation of preclinical hyperthyroidism has centred on the measurement of free thyroid hormone levels which may be elevated but frequently are within normal Another way of evaluating thyroid function in these cases is to measure thyroidal iodide uptake which parallels hormone production.s In practice uptake is more easily measured by using pertechnetate rather than iodide.
This study examined thyroid pertechnetate uptake for evidence of hyperfunction in patients Correspondence: Dr R S Jackson.
without non-thyroidal illness, who had low serum TSH but normal total thyroxine (TJ.
PATIENTS AND METHODS
The records of routine patients who had presented for thyroidal 99mTc pertechnetate uptake measurement during a 16 month period, were reviewed. Patients with normal and subnormal serum TSH at the time of the uptake test were sought. Patients with non-thyroidal illness and those on thyroxine, triiodothyronine, corticosteroids or iodine containing drugs were deliberately excluded from the study. A total of 18 male and 89 female subjects with ages from 21-94 years, remained.
All subjects were on a diet without apparent iodine excess as determined by dietary history.
The uptake of 99mTc pertechnetate by the thyroid was measured 20min after an intravenous dose of 4-5 mCi, using an International General Electric 300a small field gamma camera with parallel hole collimator. The normal range is 0.3-3-5Vo. A scintigram was also produced.
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Serum total T, and TSH were measured at the time of the uptake assessment, by the routine laboratory service, using an in-house double antibody radioimmunoassay for T, and a DELFIA immunofluorometric assay for TSH (Pharmacia Limited). The reference ranges were 60-160 nmol/L and 0-5-3-0 mU/L, respectively.
Assay of free thyroid hormones was not available routinely at the time of this study but some patients had free T, measured with an Amerlex (Amersham International plc, Buckinghamshire, UK) analogue system, reference range 3.3-8-2 pmol/L. Thyroid activity was assessed clinically at the time of the uptake measurement and subsequently for 6-20 months as part of the medical management.
To be designated as hyperthyroid, patients had to have clinical evidence of hyperthyroidism at presentation or within the follow-up period. This was judged by the attending physician, on the basis of symptoms such as weight loss, appetite increase, heat intolerance, agitation, tremor and palpitations and signs such as tachycardia, atrial fibrillation, sweating, tremor and exophthalmos.
Clarification of the diagnosis was aided by a scintigram and in some cases by the results of biopsy or cytology and autoantibody measurements. These tests do not assess net thyroid function. Uptake values were available to the clinicians but were used only to confirm hyperthyroidism diagnosed clinically.
The statistical significance of differences in serum T4 were examined using Student's unpaired t test. Sensitivity, specificity and positive predictive value were defined, respectively, as the incidence of high uptake in clinically hyperthyroid patients, the incidence of normal uptake in clinically euthyroid patients and the percentage of patients with high uptake who were clinically hyperthyroid.
RESULTS

Patients were divided into three groups:
Group 1 Normal T, with normal TSH: 40
Group 2 High T, with low TSH: 37 patients Group 3 Normal T4 with low TSH: 30 patients Each group was subdivided according to whether uptake was low (I), normal (n) or high
( h ) .
Groups 1 and 2 were, respectively, euthyroid and hyperthyroid controls for verifying the clinical validity of pertechnetate uptake measurement. Group 3 was the study group. patients Table 1 shows the sensitivity, specificity and positive predictive value of uptake measurements for clinical hyperthyroidism in all patients and those in Group 3 specifically. Table 2 gives a detailed record of the results from each of the three groups.
Group 1
The one patient with low uptake had subacute thyroiditis and was clinically euthyroid. Thirtysix patients had normal uptake. One was clinically hyperthyroid. Ten had simple goitres, six multinodular goitres, six solitary colloid nodules, three thyroglossal cysts, two carcinomas, two extrathyroidal masses, three colloid goitres, two autonomous thyroid nodules, one euthyroid Graves disease and one had a retrosternal thyroid, Three patients had increased uptake. They were clinically euthyroid; one had a multinodular goitre, one a simple goitre and one had Hashimoto's thyroiditis.
Group 2
The one patient with low uptake had subacute thyroiditis and was clinically hyperthyroid. Seven patients had normal uptake. All were clinically hyperthyroid; four had a multinodular goitre and three had Graves disease. Twenty-nine patients had an increased uptake. All were clinically hyperthyroid; 22 had Graves disease, three multinodular goitres, three autonomous thyroid nodules and one had Hashimoto's thyroiditis.
Group 3
The one subject with low uptake had subacute thyroiditis and was clinically hyperthyroid. Eighteen subjects had normal uptake; two were clinically hyperthyroid. Eleven subjects had multinodular goitres, three simple goitres, two solitary autonomous thyroid nodules, one Graves disease and one had Hashimoto's thyroiditis. Free T, was measured in seven of these subjects, one of whom had a raised level of 10.8pmoVL and clinical hyperthyroidism. The remaining six had normal free T, and were clinically euthyroid.
Mean free T, (k SEM) was 4.8 ( t 0.23) pmol/L. 
Four of these patients had multinodular goitres;
one had Hashimoto's thyroiditis and one had a solitary nodule.
Eleven subjects had increased uptake; 10 were clinically hyperthyroid. Seven subjects had Graves disease and four had multinodular goitres. Free T, was measured in four members of this group. All were clinically hyperthyroid; three had Graves disease and one had a multinodular goitre. In two the free T, was normal, 5 . 3 and 7 . 9 pmol/L and in the others it was raised, 9 . 7 and 13.4 pmol/L.
Differences in serum T, between groups In and 3n, Ih and 3h and between 3n and 3h were not statistically significant.
DISCUSSION
The pertechnetate ion is trapped by the thyroid like iodide but it is not organified.' Pertechnetate labelled with the y-emitting nuclide 99mTechnetium is used routinely to assess thyroid trapping function. The test is completed in less than an hour, is quantitative and gives a lower radiation dose compared with the use of radioiodine. An image of uptake distribution (scintigram) is produced simultaneously. This shows regional variation in thyroid pertechnetate uptake which is related to morphology but it is unsuitable for assessment of hyperthyroidism where a measure of total thyroid activity is needed.
Factors which influence the trapping of iodide also affect that of pertechnetate. These are, for example, TSH, iodide intake, corticosteroids and thyroid-stimulating immunoglobulins. Uptake correlates with thyroid hormone production.*
The description of preclinical hyperthyroidism has been based upon the finding of a suppressed TSH response in the TRH test, in the presence of normal thyroid hormone level^.^ In patients 1.3 (0.08)  1 . 3 (0.07 Other ways of confirming increased thyroid function in preclinical hyperthyroidism are needed. The use of free thyroid hormones has been examined. Although elevated free T, and free T, can be found in the presence of normal total hormone levels, they may be raised only briefly and intermittently requiring frequent serial sampling for detection.' These workers in fact found free T, to be a superior indicator of biochemical hyperthyroidism than free T,. Furthermore, TSH suppression remains long after thyroid hormone levels have returned to normal following a transient rise.I0 The utility of free thyroid hormone measurements for confirming preclinical hyperthyroidism is therefore limited.
Measurement of pertechnetate uptake by the thyroid is an established procedure and quick to perform. It has not been applied before to patients with suppressed circulating TSH, as measured by sensitive TSH assay, who are thought to have preclinical hyperthyroidism. An increased uptake might reflect the activity of circulating stimulators such as thyroid stimulating immunoglobulins or local ones such as growth factors, before thyroid hormone levels have risen ostensibly."
This study addressed only the problem of confirming hyperthyroidism in patients with suppressed serum TSH and normal thyroxine. Other circumstances associated with undetectable TSH were not examined, notably non-thyroidal illness where measurements of thyroid function may be misleading and are better delayed until after recovery.
Three patients had subacute thyroiditis and very low uptake regardless of thyroid function test results. Findings such as these are well recognized in subacute thyroiditis.I2
In patients with normal T, and TSH, euthyroid controls, 35 of the 36 with normal uptake and all three with high uptake, were clinically euthyroid. Of patients with high T, and undetectable TSH, hyperthyroid controls, seven had normal and 29 had increased uptake. They were all clinically hyperthyroid. These findings confirm previous observation of good discrimination by uptake measurement between hyperthyroidism and e~thyroidism.'~ In the study group, 10 of 11 patients who had high uptake were clinically hyperthyroid compared with only two out of 18 with normal uptake. Even a normal uptake, in the absence of TSH, suggests the presence of an abnormal thyroid stimulator. In view of the range of thyroid pathologies, increased pertechnetate uptake may reflect the activity of not only circulating thyroid stimulating immunoglobulins but also of local stimulators such as growth factors and cytokines.Il
In study group patients with normal uptake, free T, was normal in those who were clinically euthyroid and raised in the patient with hyperthyroidism. Free T, was assayed in four study group subjects with high uptake and hyperthyroidism but was raised in only two of them. This restates the limited utility of free hormone assays in preclinical hyperthyroidism, mentioned before.
In the study group, differences in hormone production between those with normal and those with increased uptake, might have been reflected in the mean levels of total T,, but the difference in T, proved insignificant. In all subjects with T, within the reference range, differences in the serum T4 between those with undetectable TSH and those with normal TSH, were not significant. This failure to show a relationship between T, and uptake may have been due to the use of total thyroid hormone measurements and infrequent sampling.
In conclusion, 97% of subjects with normal T, and TSH were euthyroid clinically on follow up and all patients with high T4 and low TSH were hyperthyroid. In the study group, who had normal T, and undetectable TSH, 11% of patients with normal pertechnetate uptake proved to be clinically hyperthyroid on follow up compared with 91% of those who had a high uptake (sensitivity 83%, specificity 94% and positive predictive value 91 Yo). These results suggest that a normal or a high uptake in the presence of a low TSH is indicative of the presence of abnormal thyroid stimulators and that measurement of pertechnetate uptake may be useful in the diagnosis of hyperthyroidism in patients with normal serum thyroxine in the presence of undetectable TSH. Further work with measurement of free thyroid hormones and abnormal stimulators is needed to confirm the findings of this retrospective study.
